Difference between revisions of "Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5 (Q9840)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1007/s00381-015-2725-3, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 1283-1289, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 25930724 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2015
| ||||||||||||||
| Property / Publication Date: 2015 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Childs Nerv. Syst. | ||||||||||||||
| Property / Published In Name String: Childs Nerv. Syst. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 31 | ||||||||||||||
| Property / Volume: 31 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English) | ||||||||||||||
| Property / title: Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 1283-1289 | ||||||||||||||
| Property / Page(s): 1283-1289 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hoffman LM
0 references
2015
0 references
Childs Nerv. Syst.
0 references
31
0 references
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English)
0 references
1283-1289
0 references
